EricaFriedmanMD

PubMed

• 57 citations
  Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.
  Michelle W. Ma, Ratna Medicherla, Meng Qian, Eleazar Vega-Saenz de Miera, Erica B. Friedman
  Modern Pathology. 2012-03-16
• 10 citations
  Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin.
  Eleazar Vega-Saenz de Miera, Erica B. Friedman, Holly S. Greenwald, Mary Ann Perle, Iman Osman
  Pigment Cell & Melanoma Research. 2012-05-01
• 13 citations
  Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations.
  Erica B. Friedman, Richard A. Scolyer, Gabrielle Williams, John F. Thompson
  Advances in Therapy. 2021-05-28

Journal Articles

• The Breast Cancer Lifestyle Intervention Pilot Study  
  Kern E, Chun J, Schwartz S, Billig J, Friedman E, Eddy M, Kiely D, Guth A, Axelrod D, Schnabel F., Journal of Cancer Therapy, 10/2014
• Expression of miR-16 if not a suitable reference for analysis of serum microRNAs in melanoma patients  
  Friedman EB, Shang S, Fleming NH, Vega-Saenz de Miera E, Hernando E, Shao Y, Osman I, Journal of Biomedical Science and Engineering, 5/2012

Abstracts/Posters

• Identification of melanoma-specific alterations in cell surface glycosylation
  Friedman EB, Rakus JF, Zavadil J, Hernando E, Mahal LK, Osman I, Journal of Clinical Oncology, ASCO, Chicago, IL, 6/2012
• MicroRNA alterations associated with BRAF status in melanoma. Proceedings of ASCO 2012 Annual Meeting
  Ma M, Farhadian JA, Friedman EB, Vega-Saenz de Miera E, Hanniford G, Segura MF, Berman RS, Shapiro RL, Pavlick AC, Zavadil J, Hernando E, Osman I, Journal of Clinical Oncology, ASCO, Chicago, IL, 6/2012
• Serum based miRNAs as prognostic biomarkers in melanoma
  Friedman E, Shang S, Vega-Saenz de Miera E, Ulrik Fog J, Ma M, Berman R, Shapiro R, Pavlick A, Hernando E, Baker A, Shao Y, Osman I, Perspectives in Melanoma XV, Brooklyn, NY, 9/2011
• Sera-based microRNAs as biomarkers of recurrence in melanoma
  Friedman EB, Shang S, Vega-Saenz de Miera E, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, Shao Y, Osman I, Proceedings of ASCO 2011 Annual Meeting, Chicago, IL, 6/2011
• Altered melanoma matrix metalloproteinase-23 (MMP-23) expression correlates with poor response to immune biologic therapy
  Krogsgaard M, Ma MW, Friedman EB, Vega-Saenz de Miera E, Darvishian F, Perez-Garcia A, Berman RS, Shapiro RL, Christos PJ, Osman I, Pavlick AC, Proceedings of ASCO 2011 Annual Meeting, Chicago, IL, 6/2011
• Join now to see all